170 related articles for article (PubMed ID: 31959018)
1. Japanese Kampo Medicine Juzentaihoto Enhances Antitumor Immunity in CD1d
Takaku S; Shimizu M; Takahashi H
Integr Cancer Ther; 2020; 19():1534735419900798. PubMed ID: 31959018
[TBL] [Abstract][Full Text] [Related]
2. Japanese Kampo Medicine Juzentaihoto Improves Antiviral Cellular Immunity in Tumour-Bearing Hosts.
Takaku S; Shimizu M; Morita R
Evid Based Complement Alternat Med; 2022; 2022():6122955. PubMed ID: 35996405
[TBL] [Abstract][Full Text] [Related]
3. CD8
Takaku S; Shimizu M; Morita R
Evid Based Complement Alternat Med; 2023; 2023():9630816. PubMed ID: 37152373
[TBL] [Abstract][Full Text] [Related]
4. Orally administered decoction of Kampo (Japanese herbal) medicine, "Juzen-Taiho-To" modulates cytokine secretion and induces NKT cells in mouse liver.
Matsumoto T; Sakurai MH; Kiyohara H; Yamada H
Immunopharmacology; 2000 Feb; 46(2):149-61. PubMed ID: 10647873
[TBL] [Abstract][Full Text] [Related]
5. Juzentaihoto Exerts Anti-Allergic Effects by Inhibiting Effector T-Cell Activation and Inducing and/or Activating Regulatory T Cells in a Murine Model of Contact Hypersensitivity.
Tsuge A; Yonekura S; Watanabe S; Kurosaki Y; Hisaka S; Nose M
Int Arch Allergy Immunol; 2022; 183(1):1-13. PubMed ID: 34818253
[TBL] [Abstract][Full Text] [Related]
6. Immune adjuvant effect of Juzentaihoto, a Japanese traditional herbal medicine, on tumor vaccine therapy in a mouse model.
Takeno N; Inujima A; Shinohara K; Yamada M; Shibahara N; Sakurai H; Saiki I; Koizumi K
Int J Oncol; 2015 Dec; 47(6):2115-22. PubMed ID: 26496932
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the Japanese traditional medicine juzentaihoto on myelosuppression induced by the anticancer drug TS-1 and identification of a potential biomarker of this effect.
Ogawa K; Omatsu T; Matsumoto C; Tsuchiya N; Yamamoto M; Naito Y; Yoshikawa T
BMC Complement Altern Med; 2012 Aug; 12():118. PubMed ID: 22876791
[TBL] [Abstract][Full Text] [Related]
8. CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity.
Li Y; Zhao C; Liu J; Lu Z; Lu M; Gu J; Liu R
Oncol Rep; 2019 May; 41(5):2679-2688. PubMed ID: 30864713
[TBL] [Abstract][Full Text] [Related]
9. CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta.
Terabe M; Khanna C; Bose S; Melchionda F; Mendoza A; Mackall CL; Helman LJ; Berzofsky JA
Cancer Res; 2006 Apr; 66(7):3869-75. PubMed ID: 16585215
[TBL] [Abstract][Full Text] [Related]
10. CD1d-restricted NKT cells contribute to the age-associated decline of T cell immunity.
Faunce DE; Palmer JL; Paskowicz KK; Witte PL; Kovacs EJ
J Immunol; 2005 Sep; 175(5):3102-9. PubMed ID: 16116199
[TBL] [Abstract][Full Text] [Related]
11. IL-12 and IL-18 induction and subsequent NKT activation effects of the Japanese botanical medicine Juzentaihoto.
Fujiki K; Nakamura M; Matsuda T; Isogai M; Ikeda M; Yamamoto Y; Kitamura M; Sazaki N; Yakushiji F; Suzuki S; Tomiyama J; Uchida T; Taniguchi K
Int J Mol Sci; 2008 Jun; 9(7):1142-1155. PubMed ID: 19325795
[TBL] [Abstract][Full Text] [Related]
12. Japanese Kampo medicine ninjin'yoeito synergistically enhances tumor vaccine effects mediated by CD8
Takaku S; Shimizu M; Takahashi H
Oncol Lett; 2017 May; 13(5):3471-3478. PubMed ID: 28529575
[TBL] [Abstract][Full Text] [Related]
13. A role for CD1d-restricted NKT cells in injury-associated T cell suppression.
Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ
J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells.
Ishikawa H; Tanaka K; Kutsukake E; Fukui T; Sasaki H; Hata A; Noda S; Matsumoto T
Virology; 2010 Nov; 407(2):325-32. PubMed ID: 20855097
[TBL] [Abstract][Full Text] [Related]
15. Mouse CD8
Li Z; Wu Y; Wang C; Zhang M
Cancer Immunol Immunother; 2019 Aug; 68(8):1303-1315. PubMed ID: 31278476
[TBL] [Abstract][Full Text] [Related]
16. CD1d-expressing breast cancer cells modulate NKT cell-mediated antitumor immunity in a murine model of breast cancer metastasis.
Hix LM; Shi YH; Brutkiewicz RR; Stein PL; Wang CR; Zhang M
PLoS One; 2011; 6(6):e20702. PubMed ID: 21695190
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic and immunomodulatory effect of the herbal medicine "Juzen-taiho-to" on malignant glioma.
Kamiyama H; Takano S; Ishikawa E; Tsuboi K; Matsumura A
Biol Pharm Bull; 2005 Nov; 28(11):2111-6. PubMed ID: 16272699
[TBL] [Abstract][Full Text] [Related]
18. Unmasking immunosurveillance against a syngeneic colon cancer by elimination of CD4+ NKT regulatory cells and IL-13.
Park JM; Terabe M; van den Broeke LT; Donaldson DD; Berzofsky JA
Int J Cancer; 2005 Mar; 114(1):80-7. PubMed ID: 15523692
[TBL] [Abstract][Full Text] [Related]
19. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
20. A nonclassical non-Valpha14Jalpha18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance.
Terabe M; Swann J; Ambrosino E; Sinha P; Takaku S; Hayakawa Y; Godfrey DI; Ostrand-Rosenberg S; Smyth MJ; Berzofsky JA
J Exp Med; 2005 Dec; 202(12):1627-33. PubMed ID: 16365146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
